A Conversation with Stephen E. Straus

Photo: Courtesy of National Center for Complementary and Alternative Medicine Stephen E. Straus is the director of the National Center for Complementary and Alternative Medicine (NCCAM), which was formally established in 1999. Prior to this appointment, he was chief of the Laboratory of Clinical Investigation at the National Institute of Allergy and Infectious Diseases. He recently chatted with reporters Brendan A. Maher and Eugene Russo. Q: Do you think there's lingering skepticism about NC

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Stephen E. Straus is the director of the National Center for Complementary and Alternative Medicine (NCCAM), which was formally established in 1999. Prior to this appointment, he was chief of the Laboratory of Clinical Investigation at the National Institute of Allergy and Infectious Diseases. He recently chatted with reporters Brendan A. Maher and Eugene Russo.

Q: Do you think there's lingering skepticism about NCCAM's creation?
A: I think there's very little skepticism left. Over the past few years, the debate went from 'Why would anyone want to study these things?' to 'How can you study these things?' to 'What are the studies showing?' The reality is the scientific community by and large has been enormously supportive of this. Our fellow institutes have been very eager to collaborate with us.

From the side of advocates for complementary and alternative medicine, their initial skepticism that we would be able to do a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Eugene Russo

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours